嘉事堂藥業股份有限公司為中國(guo)光大(da)集(ji)團股份公司下(xia)屬企(qi)業。
經(jing)共青團中央書記處批(pi)準,1997年(nian)團中央直屬企業(ye)(ye)中國青年(nian)實(shi)業(ye)(ye)發(fa)(fa)展總公(gong)(gong)司聯合中國青少(shao)年(nian)發(fa)(fa)展基金會等發(fa)(fa)起成立嘉(jia)事實(shi)業(ye)(ye)有限(xian)責任公(gong)(gong)司,1998年(nian)確(que)定(ding)醫藥(yao)經(jing)營為主(zhu)營業(ye)(ye)務(wu),更名為嘉(jia)事堂藥(yao)業(ye)(ye)有限(xian)責任公(gong)(gong)司,2003年(nian)有限(xian)責任公(gong)(gong)司整體(ti)改制為股(gu)(gu)份公(gong)(gong)司,名稱變更為嘉(jia)事堂藥(yao)業(ye)(ye)股(gu)(gu)份有限(xian)公(gong)(gong)司。2010年(nian)8月18日(ri)公(gong)(gong)司在深圳證券交易所中小板(ban)上市(shi),上市(shi)名稱:嘉(jia)事堂,證券代號002462。
嘉事堂藥業第一大(da)(da)控股股東為中(zhong)(zhong)(zhong)國(guo)(guo)(guo)青年實業發展總公(gong)司(si),2018年1月,共(gong)(gong)青團中(zhong)(zhong)(zhong)央(yang)和(he)光(guang)大(da)(da)集(ji)(ji)團簽署協(xie)議,約定中(zhong)(zhong)(zhong)國(guo)(guo)(guo)青年實業發展總公(gong)司(si)100%國(guo)(guo)(guo)有(you)產權(quan)整體(ti)劃轉(zhuan)至(zhi)光(guang)大(da)(da)集(ji)(ji)團。公(gong)司(si)實際控制人由(you)共(gong)(gong)青團中(zhong)(zhong)(zhong)央(yang)變更為中(zhong)(zhong)(zhong)國(guo)(guo)(guo)光(guang)大(da)(da)集(ji)(ji)團股份有(you)限公(gong)司(si)。其(qi)它主要(yao)股東有(you):海淀置(zhi)業、中(zhong)(zhong)(zhong)協(xie)賓館(guan)、朝(chao)陽國(guo)(guo)(guo)資(zi)委、中(zhong)(zhong)(zhong)央(yang)匯金、盛(sheng)豐順業、房山國(guo)(guo)(guo)資(zi)委、宏(hong)潤(run)投資(zi)等。
中國光大(da)集(ji)團(tuan)股份(fen)公(gong)司由財政部和匯金公(gong)司發起(qi)設立,持(chi)股比例(li)分別為44.33%和55.67%。光大(da)集(ji)團(tuan)是橫跨(kua)金融與(yu)實業(ye)、海內(nei)與(yu)海外,涵蓋銀(yin)行、證(zheng)券、保險(xian)、基(ji)金、信托、期貨、租賃、投資和環保新興產(chan)業(ye)等(deng)實業(ye)的大(da)型金融控股集(ji)團(tuan)。光大(da)集(ji)團(tuan)黨委書記、董事(shi)長李曉(xiao)鵬指出,通過五到十(shi)年時間把嘉事(shi)堂打造成為國內(nei)特色(se)醫(yi)養產(chan)業(ye)運營商。